Ra Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RARX and buy or sell other stocks, ETFs, and their options commission-free!About RARX
Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides.
CEODoug Treco, PhD
CEODoug Treco, PhD
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2008
Founded2008
Employees—
Employees—
RARX Key Statistics
Market cap2.27B
Market cap2.27B
Price-Earnings ratio-20.91
Price-Earnings ratio-20.91
Dividend yield—
Dividend yield—
Average volume2.38M
Average volume2.38M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$48.02
52 Week high$48.02
52 Week low$19.64
52 Week low$19.64
Stock Snapshot
As of today, Ra Pharmaceuticals(RARX) shares are valued at $48.00. The company's market cap stands at 2.27B, with a P/E ratio of -20.91.
During the trading day, Ra Pharmaceuticals(RARX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Ra Pharmaceuticals(RARX) stock has reached 0, versus its average volume of 2.38M.
The stock's 52-week range extends from a low of $19.64 to a high of $48.02.
The stock's 52-week range extends from a low of $19.64 to a high of $48.02.